Zhejiang Supor Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is LAMOTRIGINE, USP, with a corresponding US DMF Number 19541.
Remarkably, this DMF maintains an Active status since its submission on June 20, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 04, 2016, and payment made on August 18, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II